These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 29040331)

  • 21. Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol.
    Sanger N; Shahid H; Dennis BB; Hudson J; Marsh D; Sanger S; Worster A; Teed R; Rieb L; Tugwell P; Hutton B; Shea B; Beaton D; Corace K; Rice D; Maxwell L; Samaan MC; de Souza RJ; Thabane L; Samaan Z
    BMJ Open; 2018 Dec; 8(12):e025059. PubMed ID: 30518592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment.
    Justesen K; A Hooker S; Sherman MD; Lonergan-Cullum M; Nissly T; Levy R
    J Am Board Fam Med; 2020; 33(6):848-857. PubMed ID: 33219064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration.
    Manhapra A; Quinones L; Rosenheck R
    Drug Alcohol Depend; 2016 Mar; 160():82-9. PubMed ID: 26804898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid Use Disorder in Pregnancy.
    Roper V; Cox KJ
    J Midwifery Womens Health; 2017 May; 62(3):329-340. PubMed ID: 28561914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration.
    Jones AL; Kertesz SG; Hausmann LRM; Mor MK; Suo Y; Pettey WBP; Schaefer JH; Gundlapalli AV; Gordon AJ
    J Subst Abuse Treat; 2020 Jun; 113():107996. PubMed ID: 32359670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Counselor training and attitudes toward pharmacotherapies for opioid use disorder.
    Aletraris L; Edmond MB; Paino M; Fields D; Roman PM
    Subst Abus; 2016; 37(1):47-53. PubMed ID: 26168816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy.
    Mittal L; Suzuki J
    Subst Abus; 2017; 38(3):261-264. PubMed ID: 26672650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
    Brown JL; Gause NK; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's in a number? Recommending practicality in the DATA 2000 patient limits.
    Barthwell AG; Young JM; Barnes MC; Kulkarni SR
    J Opioid Manag; 2016; 12(4):243-50. PubMed ID: 27575825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study.
    Ober AJ; Watkins KE; Hunter SB; Ewing B; Lamp K; Lind M; Becker K; Heinzerling K; Osilla KC; Diamant AL; Setodji CM
    BMC Fam Pract; 2017 Dec; 18(1):107. PubMed ID: 29268702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.
    Borodovsky JT; Levy S; Fishman M; Marsch LA
    J Addict Med; 2018; 12(3):170-183. PubMed ID: 29432333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.
    Wilder C; Lewis D; Winhusen T
    Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.
    McNeely J; Troxel AB; Kunins HV; Shelley D; Lee JD; Walley A; Weinstein ZM; Billings J; Davis NJ; Marcello RK; Schackman BR; Barron C; Bergmann L
    Addict Sci Clin Pract; 2019 Feb; 14(1):5. PubMed ID: 30777122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava A; Kahan M; Nader M
    Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.
    Levin FR; Bisaga A; Sullivan MA; Williams AR; Cates-Wessel K
    Am J Addict; 2016 Dec; 25(8):603-609. PubMed ID: 28051841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on pharmacotherapy for treatment of opioid use disorder.
    Ayanga D; Shorter D; Kosten TR
    Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with buprenorphine versus methadone use in pregnancy.
    Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
    Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbid chronic pain and opioid use disorder: literature review and potential treatment innovations.
    Speed TJ; Parekh V; Coe W; Antoine D
    Int Rev Psychiatry; 2018 Oct; 30(5):136-146. PubMed ID: 30398071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.